• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以患者为中心的医疗管理改善抑郁结局。

Improving Depression Outcome by Patient-Centered Medical Management.

机构信息

From the Duke-National University of Singapore Graduate Medical School, Singapore; the Department of Psychiatry, Duke University Medical School, Durham, N.C.; the Department of Psychiatry, Texas Tech Health Sciences Center-Permian Basin, Midland-Odessa; the Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia; and the Corporal Michael J. Crescenz VA Medical Center, Philadelphia.

出版信息

Am J Psychiatry. 2018 Dec 1;175(12):1187-1198. doi: 10.1176/appi.ajp.2018.18040398. Epub 2018 Sep 17.

DOI:10.1176/appi.ajp.2018.18040398
PMID:30220219
Abstract

Specific challenges that profoundly affect the outcome of treatment for depression include 1) patient engagement and retention in care and optimization of treatment adherence, 2) optimization of symptom and side effect control by medication adjustments using measurement-based care procedures, 3) restoration of daily functioning and quality of life, and 4) prevention or at least mitigation of symptomatic relapse or recurrence. According to data from the Sequenced Treatment Alternatives to Relieve Depression study, some 10%-15% of patients will not return for treatment after an initial thorough evaluation visit; an additional 20%-35% will not complete the first acute-phase treatment step, and another 20%-50% will not complete 6 months of continuation treatment. Among patients who stay in treatment, over 50% exhibit poor adherence. Thus, most patients do not overcome the first two challenges. There are no systematic, widely agreed-upon psychosocial approaches to any of these four major challenges. The authors propose "patient-centered medical management" to address each of the four challenges, using psychoeducational, behavioral, cognitive, interpersonal, and dynamic models and methods. A renewed emphasis on the development and testing of systematic approaches to overcoming these common clinical challenges could enhance the chances of patient recovery and care system cost efficiencies. [AJP AT 175: Remembering Our Past As We Envision Our Future July 1933: Psychotherapeutics at Stockbridge Horace K. Richardson: "Frequently, in the simpler situations, very few interviews are required in order that he [the patient] discover for himself what part of the adaptive machinery is at fault, and for him to develop a technique of handling the maladjustment on a more satisfactory level in the future." (Am J Psychiatry 1933; 90:45-56 )].

摘要

具体的挑战,深刻地影响了抑郁症治疗的结果,包括 1)患者参与和保留在护理和优化治疗依从性,2)通过使用基于测量的护理程序进行药物调整来优化症状和副作用控制,3)恢复日常功能和生活质量,以及 4)预防或至少减轻症状复发或再发。根据缓解抑郁症的序贯治疗选择研究的数据,大约 10%-15%的患者在初次全面评估就诊后不会返回治疗;另外 20%-35%的患者不会完成第一个急性期治疗步骤,另有 20%-50%的患者不会完成 6 个月的维持治疗。在接受治疗的患者中,超过 50%的患者依从性较差。因此,大多数患者无法克服前两个挑战。对于这四个主要挑战,没有系统的、广泛认可的心理社会方法。作者提出了“以患者为中心的医疗管理”,以应对这四个挑战,使用心理教育、行为、认知、人际和动态模型和方法。重新强调制定和测试克服这些常见临床挑战的系统方法,可以提高患者康复和护理系统成本效率的机会。[《美国精神病学杂志》175 期:1933 年 7 月,回顾过去,展望未来,霍勒斯·K·理查森:“在许多简单的情况下,只需要很少的访谈,以便他[患者]自己发现适应机制的哪个部分出了问题,并开发一种在未来更满意地处理失调的技术。”(美国精神病学杂志 1933 年;90:45-56)]。

相似文献

1
Improving Depression Outcome by Patient-Centered Medical Management.以患者为中心的医疗管理改善抑郁结局。
Am J Psychiatry. 2018 Dec 1;175(12):1187-1198. doi: 10.1176/appi.ajp.2018.18040398. Epub 2018 Sep 17.
2
Novel Augmentation Strategies in Major Depression.重度抑郁症的新型强化治疗策略
Dan Med J. 2017 Apr;64(4).
3
Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression.关于提高抑郁症患者依从性、自我管理能力及治疗效果的共识性建议。
CNS Spectr. 2007 Aug;12(8 Suppl 13):1-27.
4
Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.初级保健中抑郁症心理教育复发预防项目的成本效益
J Ment Health Policy Econ. 2009 Dec;12(4):195-204.
5
People-centered tuberculosis care versus standard directly observed therapy: study protocol for a cluster randomized controlled trial.以患者为中心的结核病护理与标准直接观察治疗:一项整群随机对照试验的研究方案
Trials. 2015 Jun 22;16:281. doi: 10.1186/s13063-015-0802-2.
6
Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care.在对照试验和临床实践中最大化药物治疗的充分性:STAR(*)D基于测量的照护
Neuropsychopharmacology. 2007 Dec;32(12):2479-89. doi: 10.1038/sj.npp.1301390. Epub 2007 Apr 4.
7
Evaluation of a depression health management program to improve outcomes in first or recurrent episode depression.评估一项抑郁症健康管理计划以改善首次发作或复发抑郁症的治疗效果。
Am J Manag Care. 2003 May;9(5):374-80.
8
Collaborative management to achieve treatment guidelines. Impact on depression in primary care.通过协作管理实现治疗指南。对初级保健中抑郁症的影响。
JAMA. 1995 Apr 5;273(13):1026-31.
9
A randomized trial of relapse prevention of depression in primary care.一项初级保健中抑郁症复发预防的随机试验。
Arch Gen Psychiatry. 2001 Mar;58(3):241-7. doi: 10.1001/archpsyc.58.3.241.
10
Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.药物依从性和医疗资源利用模式的差异:老年与新型抗抑郁药在抑郁症和/或焦虑症患者中的应用
CNS Drugs. 2008;22(11):963-73. doi: 10.2165/00023210-200822110-00005.

引用本文的文献

1
Treatment-resistant depression and intranasal esketamine: Spanish consensus on theoretical aspects.难治性抑郁症与鼻内用艾司氯胺酮:西班牙关于理论方面的共识
Front Psychiatry. 2025 Aug 4;16:1623659. doi: 10.3389/fpsyt.2025.1623659. eCollection 2025.
2
Patient-centered group psychotherapy for depression and negative emotions: a systematic review and meta-analysis.以患者为中心的抑郁症和负面情绪团体心理治疗:系统评价与荟萃分析
Front Psychiatry. 2025 Jul 7;16:1530615. doi: 10.3389/fpsyt.2025.1530615. eCollection 2025.
3
An examination of symptoms, function and quality of life as conjoint clinical outcome domains for treatment-resistant depression.
对症状、功能及生活质量作为难治性抑郁症联合临床结局领域的研究。
J Mood Anxiety Disord. 2025 Apr 14;10:100121. doi: 10.1016/j.xjmad.2025.100121. eCollection 2025 Jun.
4
Perspectives on Personalized Treatment in Difficult-to-Treat Depression: A Case Report.难治性抑郁症个性化治疗的观点:一例病例报告
Case Rep Psychiatry. 2025 May 6;2025:5538951. doi: 10.1155/crps/5538951. eCollection 2025.
5
Validation of Machine Learning-Based Assessment of Major Depressive Disorder from Paralinguistic Speech Characteristics in Routine Care.基于日常护理中副语言语音特征的机器学习重度抑郁症评估方法的验证
Depress Anxiety. 2024 Apr 9;2024:9667377. doi: 10.1155/2024/9667377. eCollection 2024.
6
Investigating the psychophysiological effects of NaiKan Therapy: salivary oxytocin and cortisol release.探究内观疗法的心理生理效应:唾液中催产素和皮质醇的释放
Front Integr Neurosci. 2025 Feb 25;19:1476654. doi: 10.3389/fnint.2025.1476654. eCollection 2025.
7
The dopaminergic effects of esketamine are mediated by a dual mechanism involving glutamate and opioid receptors.艾氯胺酮的多巴胺能效应是由一种涉及谷氨酸和阿片受体的双重机制介导的。
Mol Psychiatry. 2025 Feb 19. doi: 10.1038/s41380-025-02931-3.
8
Patient Perceived Barriers and Enablers to Medication Adherence in the Treatment of Depression: A Qualitative Study.患者对抑郁症治疗中药物依从性的障碍和促进因素的认知:一项定性研究。
J Prim Care Community Health. 2024 Jan-Dec;15:21501319241286313. doi: 10.1177/21501319241286313.
9
Multilevel perspectives on the implementation of the collaborative care model for depression and anxiety in primary care.多层面视角下的基层医疗中抑郁和焦虑的协同护理模式实施。
BMC Psychiatry. 2024 Jul 22;24(1):519. doi: 10.1186/s12888-024-05930-w.
10
Facts and myths about use of esketamine for treatment-resistant depression: a narrative clinical review.关于艾氯胺酮用于难治性抑郁症治疗的事实与误解:一项叙述性临床综述
Front Psychiatry. 2024 May 15;15:1394787. doi: 10.3389/fpsyt.2024.1394787. eCollection 2024.